Nua, the Indian direct-to-consumer women's wellness brand best known for its sanitary care and menstrual health products, has raised $50 million in a Series C round led by Peak XV Partners and Filter Capital, the company confirmed on September 7, 2026. Mirabilis Investment Trust and Footpath Ventures also participated in the round, which the company said includes both primary capital and secondary share sales, allowing early backers and employees a measure of liquidity even as the business raises fresh growth capital. The round places Nua among a small cohort of Indian femtech and women's-health brands to secure a nine-figure valuation event in 2026, a year in which investor appetite for consumer health categories has been more selective than in the venture boom years.
Nua built its early reputation on organic, chemical-free sanitary pads sold through a subscription-first, direct-to-consumer model, before expanding into a broader wellness portfolio spanning period care, intimate hygiene and adjacent health categories aimed at Indian women navigating a market long underserved by mainstream personal-care conglomerates. The company has said the new funding will be directed toward three priorities: brand building at a national scale, expanding distribution beyond e-commerce into general and modern trade, and increasing investment in research and development to widen its product range. That strategy mirrors a pattern seen across India's D2C wellness sector, where digitally native brands that once relied almost entirely on performance marketing are increasingly investing in offline retail presence to compete with established FMCG players and to build the kind of brand recall that reduces long-term customer acquisition costs.
The raise also reflects a broader recalibration in how investors are approaching women-focused consumer and health startups in India. Femtech and women's wellness have historically attracted a fraction of the venture capital directed at broader consumer or fintech categories, even as market research has repeatedly pointed to significant underserved demand — the kind of gap that has drawn generalist growth investors like Peak XV into the space alongside specialist backers. Nua's ability to secure a $50 million round, at a time when many Indian consumer startups are facing tighter scrutiny on unit economics, suggests the company has demonstrated a path to profitability, or at least a credible trajectory toward it, that has satisfied institutional investors accustomed to more capital-efficient bets.
For India's wider women's health ecosystem, the round adds to a slow but steady drumbeat of capital finding its way into a category long treated as a niche rather than a mainstream consumer opportunity. Nua's next phase will test whether a brand built on category-defining products in menstrual care can extend its credibility — and its customer relationships — into the broader wellness categories it is now targeting, at a scale that justifies the fresh capital and the expectations that come with it.
